Description
Single-cell sequencing revealed unique TREM2+ microglial populations in OxPC lesions, but their specific functions remain undefined. These subsets may represent specialized responses to oxidative damage that could be therapeutically targeted.
Gap type: unexplained_observation Source paper: Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. (None, None, PMID:33603230)
Resolution criteria
Resolution requires: (1) Single-cell RNA-seq of TREM2+ microglial subsets from OxPC lesion vs. non-OxPC regions in >=6 human brain samples or >=10 mouse models identifies >=3 transcriptionally distinct TREM2+ states with unique lipid-sensing or scavenger receptor expression profiles (FDR<0.05, >=2-fold vs. homeostatic microglia); (2) Functional characterization: TREM2+ subsets isolated by FACS from OxPC lesions show >=2-fold higher uptake of OxPC liposomes (BODIPY-OxPC phagocytosis assay) and >=40% greater expression of cytoprotective genes (Hmox1, Nqo1, Gpx4) vs. TREM2- microglia, confirming an OxPC-specific defense function; (3) Genetic manipulation: TREM2 conditional knockout (Cx3cr1-Cre) in mouse atherosclerosis/OxPC model increases lesion severity >=25% and reduces cytoprotective gene expression >=50%, establishing functional necessity. Transcriptional characterization without functional validation of phagocytic or cytoprotective roles is insufficient.
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:23.218021+00:00”, “resolution_summary”: “Resolved by hypothesis h-var-799795f6af: TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming. Supporting evidence includes debate sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-004616.”, “match_counts”: {“hypothesis_matches”: 3, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-var-799795f6af”, “title”: “TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming”, “score”: 0.236, “reason”: “20 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-03-gap-aging-mouse-brain-v3-20260402”, “target_gene”: “TREM2, CSF1R”, “target_pathway”: “TREM2/CSF1R metabolic cross-talk → microglial metabolic dysfunction”, “disease”: “neurodegeneration”, “composite_score”: 0.748363, “confidence_score”: 0.78, “status”: “proposed”, “pubmed_evidence_ids”: [“20301376”, “24047521”, “28802038”, “30258234”, “31932797”]}, {“id”: “h-aa1f5de5cd”, “title”: “TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switching from protective ‘disease-associated microglia’ to neurotoxic ‘inflammasome-active’ states”, “score”: 0.222, “reason”: “17 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-02-gap-synaptic-pruning-microglia”, “target_gene”: “TREM2, TYROBP (DAP12), APOE”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.7, “confidence_score”: 0.22, “status”: “proposed”, “pubmed_evidence_ids”: [“26598730”, “27753624”, “28602351”, “28802038”, “29070674”]}, {“id”: “hyp_test_f358dd4b”, “title”: “Test: TREM2 enhances amyloid clearance”, “score”: 0.221, “reason”: “17 token overlaps; entity overlap: trem2”, “analysis_id”: “test-hypothesis-fixtures-v1”, “target_gene”: “TREM2”, “target_pathway”: null, “disease”: null, “composite_score”: 0.755, “confidence_score”: 0.333, “status”: “proposed”, “pubmed_evidence_ids”: [“40754372”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-004616”, “title”: “The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. Understanding these pathways could reveal therapeutic targets for MS neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. (None, None, PMID:33603230)”, “score”: 0.592, “reason”: “16 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b”, “quality_score”: 0.92, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-005103”, “title”: “The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. Understanding these pathways could reveal therapeutic targets for MS neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. (None, None, PMID:33603230)”, “score”: 0.592, “reason”: “16 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b”, “quality_score”: 0.68, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-004641”, “title”: “The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. Understanding these pathways could reveal therapeutic targets for MS neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. (None, None, PMID:33603230)”, “score”: 0.592, “reason”: “16 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b”, “quality_score”: 0.62, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041439-306c2cdb_task_73907230”, “title”: “The abstract describes IBA1 low/negative microglia in individuals with liver disease but provides no mechanistic explanation for this phenomenon. This represents an unexplored brain-liver axis that could impact neuroinflammation and neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Beyond Activation: Characterizing Microglial Functional Phenotypes. (2021, Cells, PMID:34571885)”, “score”: 0.415, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041439-306c2cdb”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “title”: “The abstract shows TYROBP deficiency is neuroprotective despite being required for TREM2, CD33, and CR3 function - receptors associated with AD risk. This counterintuitive finding challenges current understanding of how these immune receptors contribute to AD pathogenesis.\n\nGap type: contradiction\nSource paper: Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology. (None, None, PMID:28612290)”, “score”: 0.406, “reason”: “6 token overlaps; entity overlap: pmid, trem2”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “quality_score”: 0.56, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}